✦ LIBER ✦

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

✍ Scribed by Nizar N. Zein; for the Etanercept Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simeprevir with pegylated interferon alf

✍ Jacobson, Ira M; Dore, Gregory J; Foster, Graham R; Fried, Michael W; Radu, Moni 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 284 KB

Simeprevir with pegylated interferon alf

✍ Manns, Michael; Marcellin, Patrick; Poordad, Fred; de Araujo, Evaldo Stanislau A 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 287 KB

A Phase II, Randomized, Double-Blind, Pl

✍ Bruce R. Bacon; Mitchell L. Shiffman; Joseph K. Lim; Arthur Berman; Vinod K. Rus 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Randomized placebo controlled double bli

✍ M. Schories; B. Kallinowski; T. Goeser; K.P. Maier; A. Lutterer; V. Wietzke-Brau 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Daily dose of interferon alpha-2b and ri

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

Randomized, double-blind, placebo-contro

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB